Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based CEO’ operating in the Medical Device space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
_______
Eric Moskow
Chief Executive Officer, Director of Accuity Delivery Systems
Founder, CEO and Executive of several highly successful healthcare ventures; including DDDS, OBDS, and Cybear. Dr. Moskow is recognized as an innovative leader in the efficient operation of medical practices. He formed Outcome Based Delivery Systems, with operations in South Florida, Orlando, Florida and Las Vegas, Nevada, which OBDS sold in October 2011. From its founding in 2006 through the sale of its operations, OBDS built its revenue base from a run rate of $0 in 2006 to more than $80M in 2011. He formed Coral Gate Medical Group, a medical practice in Broward County, Florida, in January 2002 and has operated as its Managing Partner since inception. From 2002 to 2005, Coral Gate’s revenues increased from $350,000 to $3.5 million. From February 2000 through January 2002, Dr. Moskow served as Executive Vice President of Cybear, an information technology company serving the health care industry formed by Andrx Corp. He served as a Director of Cybear from June 1999 to 2002. From September 1996 to January 2000, Dr. Moskow was Executive Vice President of Strategic Planning for Phymatrix, a publicly-traded multi-specialty medical provider network. In addition, during this period and then through March 2002, he served as a Director of Phymatrix and its successor, Innovative Clinical Solutions, Ltd. (“ICSL”). From 1989 to 1997, Dr. Moskow served as an Internist and President of Family Medical Associates in Ridgefield, Connecticut. During part of this same period, from October 1995 to October 1996, Dr. Moskow served as Executive Vice President of Physician’s Choice Management, LLC (“PCM”), which he co-founded. In addition, from 1988 to 1992, Dr. Moskow served as Associate Medical Director in Connecticut for U.S. Healthcare. Dr. Moskow is board certified in internal medicine. He received his B.S. degree from Vassar College in 1980 and his M.D. degree from New York Medical College in 1984.
Follow Eric Moskow:
About Accuity Delivery Systems: Accuity Delivery Systems is a provider of clinical documentation services for the healthcare industry.
Brent Clements
Founder & CEO of Addiction Campuses of America
Brent is an accomplished entrepreneur, executive, and healthcare visionary. With over 20 years experience in senior leadership roles for multiple organizations in the healthcare and technology industries, Brent has a clear plan for what is required to build a successful company. Brent’s passion for helping those families in need inspired the founding of Addiction Campuses. Throughout his professional career Brent has developed expertise in creating strategy for the future, maximizing organizational efficiency, and building relationships with care givers, employees and community partners who drive change. Ultimately Brent believes “If they change the core belief system, the mindset changes and good behavior follows”. That is what Addiction Campuses is all about. He was recognized as one of Nashville Business Journal’s 40 Under 40 in 2011 and Healthcare Heroes nominee in 2010. Brent is married to his wife, Vicki, and they have two sons.
Follow Brent Clements:
About Addiction Campuses of America: Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.
Brad Packer
Founder and CEO of Vitality Medical
Brad is the brains behind it all. Brad started Vitality Medical in 2000 shortly after completing his graduate degree from Medical College of Virginia. While employed as a registered nurse Brad recognized the need for online medical supplies and seized the opportunity to start Vitality Medical. Working weekend nights as a nurse and weekdays as entrepreneur Brad and his team of dedicated co-workers have created one of the foremost leading companies in the online medical supply market.
Follow Brad Packer:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
Derek Lampert
Chief Executive Officer of Drive Medical
Follow Derek Lampert:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
James Flynn
Managing Partner & CEO of Deerfield Capital Management
Jim is the Managing Partner of Deerfield. He joined Deerfield in 2000, focusing on pharmaceutical companies and gradually assuming broader responsibility throughout the firm. In 2004 Jim began co-managing the firm with Deerfield’s founder, Arnold Snider. Upon Arnie’s retirement in 2005, Jim assumed his current role overseeing Deerfield’s investment activities as well as the management of the firm. Since that time, the firm has expanded its investment capabilities to include private structured financings, developed additional proprietary market research instruments through the Deerfield Institute, and created the Deerfield Foundation to contribute toward the health and welfare of disadvantaged children. Before joining Deerfield, Jim was a top ranked analyst at Furman Selz from 1996 to 2000, where he built a team to cover the pharmaceutical and medical device industries and also managed a proprietary trading account. Previously he served from 1993 to 1996 as Vice President of Corporate Development of Alpharma Inc., a pharmaceutical company, where his responsibilities included business development and strategic planning and the management of several licensing transactions. Jim began his career in healthcare investing from 1988 to 1993 at Kidder, Peabody & Co., where he ultimately served as a senior analyst covering the specialty pharmaceutical industry. Since 2009, Jim has served as the Chairman of the Quality Committee of the Board of Trustees of Continuum Health Partners until its merger in 2013 with Mount Sinai Health System, where he continues to serve on the Board of Trustees. He also serves on the Board of Trustees of the New York Academy of Medicine. He holds a B.S. in Cellular and Molecular Biology and Economics from the University of Michigan.
Follow James Flynn:
About Deerfield, Deerfield Capital Management, Deerfield Management, SaveologyHomeServices.com: Deerfield Capital Management (DCM) is a global fixed-income investment adviser
Stefano Migliorisi
Founder & CEO of swyMed Incorporated
Follow Stefano Migliorisi:
About swyMed Incorporated: swyMed’s solutions power truly mobile, real-time video telemedicine encounters at the lowest bandwidths.
Jiang Li
CEO of VivaLnk
Jiang has both passion and extensive experience in bringing innovative technology and products into the marketplace. He has held various senior management positions in both large high tech organizations and startup companies. Prior to joining VivaLnk, he was responsible for new product and technology development as the VP of engineering in Kovio and Thinfilm Electronics, leading printed electronics companies. Prior to that, he worked at AMD and the joint venture between AMD/Fujitsu, Spansion. As the VP of product engineering in Spansion, Jiang managed the major new product launches in Spansion. Jiang holds a Ph.D. degree from the University of Wisconsin-Madison, and a bachelor’s degree from Zhejiang University in China.
Follow Jiang Li:
About VivaLnk: VivaLnk is a provider of connected healthcare solutions for in-patient and remote patient monitoring.
Sahil Diwan
Co-Founder & CEO of SafKan Health
Follow Sahil Diwan:
About SafKan Health: Ear care for the 21st century.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Maury Blackman
President & CEO of Premise Data
Maury Blackman is CEO of Premise Data. Blackman is a tech executive with more than 25 years of experience leading high growth enterprise software companies. His industry experiences include government, construction, public safety, geospatial information, GPO’s, sharing economy services, and drone software. Blackman joined Premise in 2017; under his leadership the company has seen 661% revenue growth. In November 2020, Premise was named to Deloitte’s Technology Fast 500, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Premise is the 35th fastest-growing company in the Silicon Valley region and is 182nd on the overall list. Before joining Premise, Blackman was CEO at Accela, a civic tech company aimed at moving citizen transactions from city hall to online and mobile services. He joined the company in 2000 as the VP of Sales and Marketing and then assumed the role of CEO in 2007. To support strategic initiatives and growth, he raised more than $300M in financing from family offices, private equity, and senior debt. The capital from these raises was deployed to build out an enterprise offering, expand internationally, and execute an M&A strategy that closed 10+ acquisitions in 24 months. Prior to joining Accela, Maury worked for Investools (NASDAQ:IEDU) where he served in several executive positions from 1993 to 2000. At Investools, he first joined as an Account Executive and was later appointed Vice President, Business Development charged with selling data and content to brokerage firms and internet service providers in the nascent dot-com era. In this capacity, he built a dynamic portfolio of accounts that included Charles Schwab, Fidelity, AOL, and Netcom Online Communications. For his accomplishments at Accela, Blackman was recognized by Government Technology as one of its Top 25 Doers, Dreamers, and Drivers in 2015. In 2016, Ernst and Young awarded him the prestigious Northern California’s Entrepreneur of the Year. Maury holds a B.A. in Political Science from the University of Houston and was a commissioned field artillery officer in the United States Army, serving on both active and reserve duty for 10 years. Maury maintains an active lifestyle and is an eleven-time Ironman finisher, including the 2008 and 2013 Ironman World Championship in Kailua-Kona.
Follow Maury Blackman:
About Premise Data: Premise is a data and analytics platform powered by a global network of on-the-ground contributors, data science, and machine learning.
Jonathan M. Rothberg
Co-Founder, Product Architect & CEO of Butterfly Network
Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.
Follow Jonathan M. Rothberg:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Mehdi Maghsoodnia
Founder and Chief Executive Officer of 1Health
Mr. Maghsoodnia is currently serving as CEO of 1Health.io and Vitagene. He is also on the board of SpineZone and MedCorder. He previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. Mr. Maghsoodnia is a industry fellow at UC Berkeley where he teaches innovation and entrepreneurship. He studies EECS in UCB and Stanford with an emphasis in AI and Machine learning.
Follow Mehdi Maghsoodnia:
About 1Health: 1health’s Testing as a Service (TaaS) Solution empowers precision testing and end-to-end process management in one simple, scalable tool.
James C. Katzaroff
CEO, Chairman and Founder of Vivos Inc
A serial entrepreneur who started his first company importing minerals and pewter from Brazil while in high school in southern California, Mr. Katzaroff is constantly searching for outstanding opportunities. Hired straight out of college Mr. Katzaroff was a financial consultant for Wall Street firms Bateman Eichler, Smith Barney and EFHutton. Since 1990, he has been responsible for corporate engineering, senior-level corporate strategy, fostering investment bank relationships, and has served as a senior financial advisor for numerous start-ups and development stage companies. A strong desire to make an unshakable impact in the fight against cancer led Mr. Katzaroff to found AMI in 2006.
Follow James C. Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Kim D. Blickenstaff
President and Chief Executive Officer of Tandem Diabetes Care
Kim joined Tandem in August 2007, bringing more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. Prior to joining Tandem, he was Chairman, Chief Executive Officer and co-founder of Biosite Incorporated, a medical diagnostic company that was acquired by Inverness Medical Innovations for $1.8 billion in June 2007. Prior to founding Biosite, he held various finance, operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter Healthcare. Kim has been active in the medical device and diagnostics industry over the last 12 years, serving on the board of directors for innovative, young healthcare companies such as SenoRx and MediVation Incorporated. He holds a Masters of Business Administration from Loyola University Chicago’s Graduate School of Business.
Follow Kim D. Blickenstaff:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Wei-Wu He
Founder and CEO of Origene Technologies
Wei-Wu He is a biotech executive dedicated to the commercialization of innovative life sciences technologies for the healthcare market.He is currently Chairman and CEO of OriGene Technologies, Inc. He is also the founder and General Partner of Emerging Technology Partners, LLC (ETP), a venture firm dedicated to incubating innovative life sciences companies. He is also a Venture Partner of IDG/Accel Partners, a $4 Billion venture fund designed to fund innovative companies in China.He started his biotech career as a scientist at the inception of Human Genome Sciences, Inc.He has been involved in the funding and founding over 20 biotech companies throughout his career and has served on many biotech company boards. Most recently He was named the Executive Chairman of Casi Pharmaceuticals, a biotech company dedicated to the development of innovative cancer treatments both in China and the US.He has conducted cancer research at Mayo Clinic and at Massachusetts General Hospital as a research fellow. He has been awarded over 30 United States patents and has more than 25 original research publications.He received a Bachelor’s degree in Biochemistry from Nanjing University, P. R. China, an M.B.A. from Wharton School of the University of Pennsylvania, and a Ph.D. in Molecular Biology from Baylor College of Medicine.
Follow Wei-Wu He:
About Emerging Technology Partners, Origene Technologies: OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.
Paul Molloy
President & CEO of ClearFlow
Paul has over twenty years experience of operations, executive management and Board work at public, private and VC funded medical device companies. Two IPO’s at previous companies, particularly as President & Managing Director orchestrating LMA’s successful 2005 SGX listing at a market capitalization of >$300m. LMA was recently acquired by Teleflex in a process that he brokered. Paul was a practicing CRNA until he joined Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and rising through executive positions with leading medical device firms to CEO level in successive start ups, most recently completing the sale of VasoNova to Teleflex Inc. He has extensive global industry connections and has traveled, lived and worked in Asia, Europe and the USA, including substantial experience setting up and managing operations in Australia, Germany, Switzerland, Singapore, China, Japan, India and Latin America as well as serving on the Board of those local subsidiaries.
Follow Paul Molloy:
About ClearFlow: ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Fei Li
Chief Executive Officer & Chairwoman of Hycor Biomedical LLC
Fei Li first joined Hycor in 2016 as President and Chairwoman of the Board. In September 2017, she became President and CEO of Hycor. Dr. Li has over 20 years’ experience in the fields of in vitro diagnostics (IVD), medical devices and Clinical Medicine. Over her distinguished career, Dr. Li has consistently demonstrated her ability to deliver results as she has led teams that improved product design, realized operational efficiency and recognized investment opportunities in the domestic and international healthcare sector. Dr. Li’s strengths include her extensive experience in building and empowering a team to manage through organizational growth to improve processes, decrease costs and accelerate business performance. Dr. Li also has extensive investment experience in the healthcare industry. She has successfully executed cross-border transactions and has been effective in managing pre- and post-investment activities between stakeholders and investment targets. Dr. Li has had the distinction of serving in multiple strategic roles including Chief Operating Officer for QuantumTech Medical Devices during 2016-2017, Chief Operating Office for Beyond Diagnostics Inc. between 2008 – 2011, Head of Business Development for Siemens Healthcare China from 2007 – 2008 and Director of Product Validation for Diagnostic Products Corporation from 2006 – 2007. Dr. Li holds a medical degree from San Yat-Sen University in Guangdong, China. In addition, she received a Ph.D. degree in Biomedical Sciences from the University of California, Riverside and a Master of Business Administration (M.B.A.) from the University of Redlands.
Follow Fei Li:
About Hycor Biomedical LLC: Hycor Biomedical is a medical device company that provides vitro diagnostics products.
Jeff Dachis
Founder, Chairman & CEO of One Drop
After Jeff Dachis was diagnosed with type 1 diabetes, he set out to create a data-driven digital platform that would disrupt the reactive healthcare model. In 2015, One Drop was born. The precision health company combines continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people worldwide living with diabetes and other chronic conditions.
Next, One Drop plans to enter the market with a daily disposable, minimally invasive continuous health sensor in development designed to provide greater flexibility and insights for people living with diabetes compared to fingersticks alone. The availability of this proprietary sensor is subject to receipt of clearance or approval from the U.S. FDA. Before One Drop, Dachis co-founded Razorfish (NASDAQ: RAZF) and led its $55MM IPO, then founded the Dachis Group (acquired by Sprinklr).
Dachis has appeared on Crain’s 40 Under 40 list and was named EY Entrepreneur of the Year. An internet pioneer, having helped create the first banner ad and web animation, Dachis now channels his passion for data, technology, and design at One Drop, building data-driven products that empower people to take charge of their health.
Follow Jeff Dachis:
About One Drop: One Drop is a diabetes management platform that helps people navigate diabetes together.
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Maria Artunduaga
Founder and CEO of Respira Labs
Follow Maria Artunduaga:
About Respira Labs: Respira Labs is building an AI-powered sensor platform to track, predict, and prevent chronic lung disease.
Omri Shafran
CEO of Texas Medical Technology
Follow Omri Shafran:
About SureSpot, Texas Medical Technology: Texas Medical Technology specializes in the sale and distribution of wide range of medical equipment.
Marc Korczykowski
CEO and Co-Founder of Hura Imaging
Marc Korczykowski is Hura Imaging’s Co-Founder and CEO.
Follow Marc Korczykowski:
About Hura Imaging: Hura Imaging develops and commercializes novel CT technology that decreases radiation dose significantly in patient management.
Austin Pittman
CEO of UnitedHealthcare Community & State
Austin Pittman is the President at Powderhorn Ventures, LLC.
Follow Austin Pittman:
About Blue Norther Hard Seltzer, Gauge Capital, Optum, Powderhorn Ventures, UnitedHealthcare Community & State: UnitedHealthcare Community & State is the premier provider in the United States of high quality, personalized public sector health care.
Stephen Chen
Founder & CEO of Scanwell Health
Co-Founder and President at Learn To Be Foundation. Founder at Petnostics.
Follow Stephen Chen:
About Learn To Be Foundation, Petnostics, Scanwell Health: Scanwell Health is an FDA-cleared urine testing application.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Paul Grand
CEO of MedTech Innovator
Follow Paul Grand:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
Uday Kumar
Founder, President, CEO, and Board Member of Element Science
Co-Founder & Board Member at Sympara Medical – Dr. Uday N. Kumar, a cardiologist and cardiac electrophysiologist by training.
Follow Uday Kumar:
About Element Science, Stanford University, Sympara Medical: Element Science is a medical device and digital health start-up that develops lifesaving wearable solutions.
Harel Gadot
Co-Founder & CEO of Microbot Medical
Harel Gadot is a co-founder of Microbot Medical and has been serving as the CEO since its inception and the Chairman of the Board since 2013. He is also the Chairman of XACT Robotics Ltd., another promising medical robotics company, specializing in the field of needle steering for medical procedures such as biopsies. Until 2013, he was a board member at ConTIPI Ltd. Which was acquired in 2012 by Kimberly Clark. Prior to founding Microbot Medical, he served as a Worldwide Group Marketing Director at Johnson & Johnson (Ethicon Inc., Somerville NJ), overseeing the company’s global strategic marketing. Prior to this, he was the Regional Marketing Manager at Johnson & Johnson (Ethicon Inc., Paris, France), responsible for the strategic marketing for Europe, Middle East and Africa. During his tenure, both companies enjoyed continuous growth in revenues and new product launches. Prior to this, Harel held several management positions in marketing and sales at Johnson & Johnson Medical Israel. He is a guest speaker for management and innovation courses at leading universities in the United States and Israel, and holds a Bachelor of Science (BS) from Siena College (USA) and a Master in Business Administration (MBA) from Manchester University (UK).
Follow Harel Gadot:
About MEDX Ventures Group, MEDX Xelerator, Microbot Medical: Microbot Medical is the first medical device company specialized in the researching, designing, developing and commercializing.
Kristina Cahojova
Founder & CEO of kegg
Kristina Cahojova is the Founder and CEO of Kegg.
Follow Kristina Cahojova:
About kegg: Kegg is a two-in-one device that combines fertility tracking with pelvic floor exercising.
Matthew Putman
Co-Founder & Chief Executive Officer of Nanotronics Imaging
Matthew Putman Co-Founded Nanotronics Imaging, LLC in 2008 and serves as its Chief Executive Officer. Matthew Putman is a Professor and Researcher at Columbia University. He was an owner and Vice President of Development for Tech Pro, Inc., which was acquired by Roper Industries in March 2008. During his time at Tech Pro, he lead two acquisitions, and the transformation of the instrument manufacturer into new global markets, having formed partnerships or subsidiaries in 15 nations. He serves as a Director of Nanotronics Imaging, LLC. He has lectured at The University of Paris, USC, University of Michigan, and The Technical University of Sao Paulo. He has also produced several plays and films, and is an accomplished composer. He is a founding member of the World Science Festival. He is on the Executive Board of the Montauk Observatory, and is an Artist in Residence for Imagine Science Films. He holds 5 patents, and has published over 20 technical papers, and in 2002 he won the ACS Best Paper Award. He has a Ph.D. in Applied Physics.
Follow Matthew Putman:
About Nanotronics Imaging, The Thiel Foundation: Nanotronics Imaging is a microscopy and software company delivering rapid testing and analysis solutions.
Thomas Oxley
CEO & Founder of Synchron
Thomas Oxley is the CEO at Synchron
Follow Thomas Oxley:
About Defence Science and Technology, Florey Institute of Neuroscience & Mental Health, Mount Sinai Health System, Synchron, Synchron, University of Melbourne, VascuLab: Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
George Palikaras
Founder, President/CEO of Metamaterial Inc.
Founder at Metamaterial Technologies
Follow George Palikaras:
About Metamaterial Inc.: Mastering Light using Smart Materials & Photonics. Changing the way we use, interact and benefit from Light.
Vivek Kopparthi
CEO, Co-Founder & Executive Chairman of NeoLight
Vivek Kopparthi is Co-founder & CEO of NeoLight, a lean medical device start-up developing a disruptive technology to treat Jaundice in infants.
Follow Vivek Kopparthi:
About NeoLight, PriZm Therapeutics: Neolight is a medical device company that develops phototherapy beds to cure jaundice in pre-term and full term babies.
Joseph DeVivo
CEO of InTouch Health
Joseph M. DeVivo, Chief Executive Officer of InTouch Health, brings a proven track record of 30 years of extensive business leadership and 25 years of medical device experience, ranging from small startups to large corporations. Prior to joining InTouch Health, Joseph served as President, Chief Executive Officer and Director at Angiodynamics (NASDAQ: ANGO) from September 2011 through the summer of 2016. Joseph also held positions as Global President of Smith & Nephew Orthopedics (NYSE: SNN) between 2007 to 2011, President and Chief Executive Officer and Director of RITA Medical Systems, Inc. from 2003 to 2007, President, Chief Operating Officer and Director of Computer Motion Incorporation (CMI) from 2002 to 2003, and Vice President, General Manager at U.S. Surgical/Davis (USS/DG), a division of Tyco International’s Healthcare Business, from 1993 through 2002. Joseph received his Bachelor’s degree in Business Administration from the E. Clairborne Robins School of Business at the University of Richmond in 1989. Active in industry leadership as well as philanthropy, Joe is a member of the board of Mauna Kea Technologies, (EPA:MKEA) and St. Jude’s Children’s Research Hospital raising over $1,000,000 for the benefit of the Hospital.
Follow Joseph DeVivo:
About AngioDynamics, AngioDynamics, Computer Motion, Inc, InTouch Health, RITA Medical Systems, Inc, SurgiQuest: InTouch Health is the leader in Acute Care Telemedicine solutions.
Geoffrey Chaiken
Co-founder & CEO of Blink Health
Geoffrey Chaiken is the Co-Founder & Chief Executive Officer of Blink Health. As the first e-commerce company to bring prescriptions online, Blink Health solves the prescription drug pricing problem in the US by offering patients amazingly inexpensive Rx prices. Patients simply pay for their prescriptions online, before picking them up at their preferred pharmacy or having them delivered to their home. Previously, Geoffrey was the founder of Marinus Pharmaceuticals (Nasdaq: MRNS), a specialty pharmaceutical company developing novel treatments for severe epilepsy. Prior to founding Blink Health, Geoffrey was at Brave Warrior Advisors, where he was one of three investors managing $3 billion. At Brave Warrior, Geoffrey led the firm’s successful investment throughout the technology and pharmaceutical supply chains. Geoffrey has a BA in Biology and Philosophy from Yale University and an MBA from Harvard Business School. Geoffrey has been named Fortune’s 40 Under 40 and several other lists of top leaders in healthcare and business.
Follow Geoffrey Chaiken:
About Blink Health: Blink Health is a web-based application that enables users to search for medical prescriptions online and pick them up from any pharmacy.
Surendar Magar
President and CEO of LifeSignals
Surendar Magar has over 30 years’ experience in the technology industry. He co-invented the Texas Instruments TMS320, the groundbreaking digital signal processing architecture that launched the DSP industry. Later he co-founded Athena Semiconductors, an early developer of the wireless networking platform that would become Wi-Fi; Athena was acquired by Broadcom Corporation.
Follow Surendar Magar:
About LifeSignals: LifeSignals’ offers innovation in wearable biosensor technologies to address a broad set of needs and opportunities throughout healthcare.
William Facteau
CEO of Earlens
Follow William Facteau:
About Earlens: Earlens is a privately held medical technology company transforming the hearing experience with the only direct sound delivery system.
Shantanu Gaur
Co-Founder & CEO of Allurion Technologies
Shantanu Gaur co-founded Allurion in 2009 during his second year at Harvard Medical School and is our Chief Scientific Officer. A Paul & Daisy Soros Fellow, Shantanu graduated summa cum laude and Phi Beta Kappa from Harvard College with an S.B. in Biology and significant coursework in polymer chemistry. Shantanu graduated from Harvard Medical School in 2013. He grew up in Pittsburgh, Pennsylvania and lives in Cambridge, Massachusetts.
Follow Shantanu Gaur:
About Allurion Technologies, Genetic Alliance: Allurion Technologies develops a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Alex Gorsky
Chairman & CEO of Johnson & Johnson
Follow Alex Gorsky:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Alamin Uddin
Co-founder & CEO of NexHealth
Alamin Uddin is a Co-founder & CEO of NexHealth.
Follow Alamin Uddin:
About NexHealth: NexHealth is a real-time patient booking platform for people, their doctors, and healthcare developers.
Farhad Khosravi
Chairman & CEO of Imperative Care
Farhad Khosravi is the Executive Chairman and Co-Founder at Tulavi Therapeutics.
Follow Farhad Khosravi:
About Access Closure, Embolic Protection, Hotspur Technologies, Imperative Care, Imperative Care, Incept, Instylla, Ocular Therapeutix, Ostial Corporation, Tulavi Therapeutics, Tulavi Therapeutics: Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Greg Colip
Founder, Managing Member & CEO of Cell Point
Since its beginning, Greg Colip is a founding member of Cell>Point and has provided financial support to the company. Mr. Colip brings over 38 years of experience in healthcare marketing and legal. Prior to establishing the company with Jerry Bryant and Terry Colip, Mr. Colip was a corporate mergers and acquisition lawyer and served as Deputy General Counsel for Panhandle Eastern Corporation (which has since been split up with part of the company’s subsidiaries owned by Duke Energy and the remaining part-owned by CMS Energy), provided legal counsel and development work for various independent power projects, served as Vice President and General Counsel for the Gulfco Division of Chromalloy American Corporation and was a production/marketing manager for The Upjohn Company (now part of Pharmacia). At Panhandle Eastern, Mr. Colip was involved in numerous complex venture, merger, spin-off, and acquisition transactions, including the $2.4 billion acquisition of Texas Eastern Corporation and the $1.2 billion drop down and spin-off of Anadarko Petroleum Corporation. At Upjohn, Mr. Colip was the production/marketing systems manager for the corticosteroid and anticoagulant product lines. Mr. Colip received his bachelor’s degree in production management and industrial engineering in 1970, followed by his M.B.A. two years later and a J.D. in 1978. His higher education was at Indiana University, and Greg is proud to call it his Alma Mater.
Follow Greg Colip:
About Cell Point: Cell Point is a biotechnology company developing universal molecular imaging agents and intra-nuclear metallic therapeutics.
Leonide Saad
Founder, President & Chief Executive Officer of Alkeus Pharmaceuticals
Dr. Saad founded Alkeus Pharmaceuticals with the goal of developing sight-saving, transformative medicines for the most serious and untreatable causes of blindness. Prior to Alkeus, he was partner in a boutique life sciences management and consulting firm in New York City, providing business and strategic guidance to biotechnology and pharmaceutical companies. He was previously at Proteus Venture Partners, an early stage, California based venture fund focused on stem cells and regenerative medicine. Dr. Saad holds a PhD focused on tissue engineering from MIT, a certificate of Financial Technology from MIT Sloan School of Management, a MS in Mechanical Engineering from MIT, a BS and MS in Applied Mathematics from University of Paris VI, and is a graduate from Ecole Polytechnique, Paris, with a concentration in organic chemistry and physics.
Follow Leonide Saad:
About Alkeus Pharmaceuticals: Alkeus Pharmaceuticals Inc., a Boston-based startup focused on treatments for serious ophthalmic conditions.
Robert Ford
President & Chief Executive Officer of Abbott
Follow Robert Ford:
About Abbott: Abbott is engaged in pharmaceuticals and manufacturing healthcare products.
Christian Gormsen
CEO of Eargo
Growing up across the world, Christian dreamed about a career in the NBA, but alas that was not to be. So, he decided on a wildly successful career in the hearing health and professional services industry instead. Over two decades, Christian has been instrumental in growing the hearing health and professional services market for leading global companies. We lured him from Copenhagen with the promise of a try-out with the Golden State Warriors.
Follow Christian Gormsen:
About Eargo: Eargo makes direct-to-consumer hearing aids, allowing customers to access help for their hearing loss from their homes.
Ben Lewis
CEO of Limbix
Ben Lewis is the co-founder of Tapjoy. He has an undergraduate degree in engineering from the University of Michigan, and his first job out of college was working as an engineer on Xbox Live. After spending some time at Microsoft, he returned to Michigan for his MBA where he focused on entrepreneurship and technology. Ben then moved to Google where he spent 4 years as a Product Manager, working on products such as the Toolbar, Search, and Checkout. Ben left Google to found Tapjoy, which began with the launch of TapDefense. Ben now leads the Tapjoy product team and manages accounts for the top publishers.
Follow Ben Lewis:
About Green Shoots Distribution, Limbix: Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.
Konstantinos Alataris
Founder, CEO of Nesos
Konstantinos Alataris is the President and CEO of the Nevro Corp. Prior to founding Nevro, Dr. Alataris was a venture capitalist with Bay City Capital in San Francisco, focusing on investment and strategic advisory services. He was previously a Business Development Manager with Compass, Guidant’s Corporate Venturing Group, where he analyzed and structured medical device/healthcare investments and evaluated acquisition targets. He was also a Research Fellow at the House Ear Institute, a research center and clinic in Los Angeles. Dr. Alataris holds a Ph.D. in Biomedical Engineering, an MBA, and an M.S. in Electrical Engineering from the University of Southern California. He received a BS in Electrical Engineering and Computer Science from the National Technical University of Athens, Greece.
Follow Konstantinos Alataris:
About Nesos: Nesos develops wearable interfaces and software components for the treatment of neurological disorders.
Joseph Huang
CEO of StartX (Stanford-StartX Fund)
Follow Joseph Huang:
About StartX (Stanford-StartX Fund): StartX is an educational non-profit that helps Stanford’s top entrepreneurs.
Martyn Gross
Co-Founder & CEO of Zerigo Health
Advisor at Cooler Heads Care & Chief Business Officer at Mindera.
Follow Martyn Gross:
About Dthera Sciences, MiNDERA Corporation, Zerigo Health: Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .
Julia Taylor Cheek
CEO and Founder of EverlyWell
Julia Taylor Cheek is the CEO and Founder of EverlyWell, a digital health startup empowering consumers to order, self-collect, and understand lab tests. Based in Austin, EverlyWell launched in June 2016 after raising $3M in capital and garnering awards from Tech Crunch and Rock Health. They now have over 5,000 customers in 46 states. Julia was also named the number one female entrepreneur to watch by CIO magazine for 2017. Prior to founding EverlyWell in 2015, Julia was the Vice President of Corporate Development and Strategy at MoneyGram International, a public financial services company that operates in 200 countries. As the youngest VP in the company, she worked for MoneyGram’s CFO for several years, leading corporate transactions, restructuring projects, and special projects for the CEO. Before that, she served as the founding Director of Strategy and Operations at the George W. Bush Institute and played a key role in building the organization from just a handful of employees to the Presidential Center that you see today at Southern Methodist University. After attending Vanderbilt, Julia started her career in management consulting at Deloitte and went on to earn her MBA from the Harvard Business School, where she graduated as a Baker Scholar with high distinction. She also is a former multiple World Champion equestrian, officially retiring in 2009.
Follow Julia Taylor Cheek:
About EverlyWell: EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.
Sanket Baralay
President & CEO of FIGMD
Sanket is a Health IT expert, innovator and entrepreneur. As the head of FIGmd he has pioneered groundbreaking products, processes and services and has established partnerships with some of the country’s largest medical societies. Prior to FIGmd, Sanket led business and technology companies that focused on developing and delivering solutions for the healthcare industry.
Follow Sanket Baralay:
About FIGMD: FIGMD is a U.S.-based provider of healthcare quality measurement and improvement solutions.
Amarpreet Sawhney
CEO of Instylla
Amar is the President and CEO of Octux, Inc. a company focused on unmet needs in ophthalmic surgical wound closure and drug delivery. Previously, he was Founder and CEO of Confluent Surgical (acquired by Covidien), a biosurgery company. He was Chairman of marketRx (acquired by Cognizant), a provider of pharmaceutical marketing and sales analytics and intelligence. Before Confluent, Amar was the technology founder of Focal, Inc. (acquired by Genzyme). Amar’s innovations are the subject of almost 100 issued and pending patents. He is a board member of Soteira, Square One and TiE Boston. He is a board member and founder of Access Closure, Octux, Augmenix, and Incept LLC. Amar volunteers his time with entrepreneurial organizations including TiE Boston, MassMedic, and the E&Y Entrepreneur of the Year program. Amar and Confluent have been recognized with awards including MassMedic best startup company award, Frost and Sullivan Product innovation award, MIT Global Indus Technovators Award, E&Y regional entrepreneur of the year award, Mass High Tech All Star award, and University of Texas Outstanding Young Engineering Graduate award. Amar holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from the Indian Institute of Technology, New Delhi.
Follow Amarpreet Sawhney:
About Incept, Instylla, SpaceOAR: Instylla’s focus is to leverage hydrogel technology .
Connor Landgraf
Co-Founder & CEO of Eko Health
Connor Landgraf is the co-founder and CEO of Eko.
Follow Connor Landgraf:
About Eko Health: Eko develops AI-powered digital tools to detect and monitor heart and lung disease
Wenbin Jiang
Co-Founder and CEO of Cytek Biosciences
Wenbin Jiang is a co-founder of Cytek Biosciences, Inc. and a seasoned entrepreneur and inventor. E2O communications was the first company he cofounded in late 1990s, which was acquired by JDS Uniphase in 2004. He is an inventor of more than 90 US patents and an author of 4 book chapters and more than 50 peer reviewed technical papers.
Follow Wenbin Jiang:
About Cytek Biosciences: Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
Maurice Ferre, M.D.
CEO & Chairman of InSightec
Dr. Maurice R. Ferré was the founding President and Chief Executive Officer of MAKO Surgical Corp, serving from 2004 until the acquisition of the company by Stryker Corp. for $1.7 billion in 2014. In June 2007, Dr. Ferré received the Ernst & Young Entrepreneur of the Year 2007 award for emerging companies in Florida. In 1993, he founded Visualization Technology, Inc., a medical device company for image-guided surgery, where he served as Chief Executive Officer until 2002 when the company was acquired by GE Healthcare, the healthcare division of the General Electric Company. Dr. Ferré served as Vice President of Strategic Development for GE Navigation, a Division of GE Healthcare, until 2004. Dr. Ferré holds an M.D. and a Master’s degree in Public Health from Boston University.
Follow Maurice Ferre, M.D.:
About DermaSensor, InSightec: InSightec develops and manufactures MR-guided Focused Ultrasound technology devices for image-guided acoustic surgery.
Julia Hu
CEO of Lark
Having been too often sleep deprived and dropping off exercise and diet regimens, Julia’s goal is to make people happier and healthier as the CEO of lark technologies. Named Top 10 Most Innovative CE Companies in the World by Fast Company, lark is a mobile and wireless technology company that uses behavior change to personally coach people to feel great. A serial entrepreneur, she has focused on growing early-stage startups in the consumer products and cleantech space. Prior to lark, she ran global startup incubator Clean Tech Open, her own green buildings startup, and worked in China to build consumer electronics with D.light Design. She received her master’s and bachelor’s degrees at Stanford University and half a MBA from the MIT Sloan (a dropout, but they were kind enough to make lark a casestudy). She was an entrepreneur in residence at Stanford’s StartX incubator, and named Top Woman Entrepreneur Under 40 by Marie Claire Magazine.
Follow Julia Hu:
About Lark: Lark is a digital health startup that provides virtual care through AI coaching, smart devices, and tele-monitoring.
Brent Shafer
Chairman & CEO of Cerner
As chairman of the board of directors and chief executive officer of Cerner, Brent Shafer focuses on growing and expanding Cerner’s market-oriented business units, consumer brand, key strategic relationships and priority corporate initiatives. Previously chief executive officer of Philips North America, Shafer oversaw a health technology portfolio that included a broad range of solutions and services covering patient monitoring, imaging, clinical informatics, sleep and respiratory care as well as a group of market-leading consumer-oriented brands. Shafer also was previously the chief executive officer of the global Philips Home Healthcare Solutions business. Shafer has extensive experience driving value-based business models from a foundation of innovation. He has helped lead the growth of a complex multinational organization over a number of years in senior leadership positions with Philips. He has also served in senior leadership positions at other companies, including GE Medical Systems, Hill-Rom and Hewlett-Packard. Shafer started his career at Intermountain Healthcare’s Primary Children’s Hospital. He serves on the board of No Barriers USA, a nonprofit that organizes life-changing experiences for youth, veterans and people with disabilities. Shafer is also active in the Health Management Academy, a community of executives from the largest U.S. integrated health systems and most innovative health care companies. He has a bachelor’s degree from the University of Utah.
Follow Brent Shafer:
About Cerner, Philips: Cerner is a supplier of healthcare information technology solutions, services, devices, and hardware.
Florian Bohn
CEO & Co-Founder of GuRu
Florian has always felt compelled to understand the way the world works. His curiosity moved him to study Electrical Engineering at Caltech (B.S. Cum Laude), to receive an M.S. in Electrical and Computer Engineering from UC Santa Barbara, and a Ph.D. in Electrical Engineering from Caltech. At GuRu, Florian is thrilled to be building technology that will enrich people’s lives on a global scale. He is also proud to be building a community of passionate and like-minded engineers at the organization. As a co-founder and CEO at GuRu, Florian brings years of technology experience. At Axiom Microdevices, he helped define and implement high-frequency RF integrated circuits which have shipped more than 400 million units. At Agilent Laboratories (formerly HP Labs) he worked on clock and data recovery circuits as well as novel test and measurement systems. As a Caltech Lead Scientific Researcher, Florian guided engineering and operational aspects of implementing the microwave system at Caltech’s Space Solar Power Initiative.
Follow Florian Bohn:
About GuRu: Enables safe, effective and customizable transmission of power over-the-air using proprietary mmWave and Smart RF Lensing technology
Greg Benoit
CEO of QGenda
Greg Benoit is the CEO at QGenda.
Follow Greg Benoit:
About QGenda: QGenda is the leading innovator in enterprise healthcare workforce management solutions.
Gary Guthart
CEO of Intuitive Surgical
Gary Guthart joined Intuitive Surgical in April 1996. Effective January 2010, Guthart was appointed as Chief Executive Officer. In July 2007, he was promoted to President. Prior to that, in February 2006, Guthart assumed the role of Chief Operating Officer. Prior to joining Intuitive, Guthart was part of the core team developing foundation technology for computer enhanced-surgery at SRI International (formerly Stanford Research Institute). Guthart is currently a member of the Board of Directors of Affymetrix, Inc. He received a B.S. in Engineering from the University of California, Berkeley and an M.S. and a Ph.D. in Engineering Science from the California Institute of Technology.
Follow Gary Guthart:
About Intuitive Surgical: The da Vinci Surgical System is changing the experience of surgery for patients around the world.
Richard Lin
CEO & Co Founder of Ombre
Follow Richard Lin:
About Ombre: Ombre is a provider of a microbiome testing kit designed to incorporate personalized probiotics and microbiome testing.
William Herlands
CEO and Co-Founder of Willow
Will Herlands is the CEO of Willow. After graduating from Princeton University where he studied electrical engineering, Will worked at MIT Lincoln Laboratory conducting research on AI, robotics, and cybersecurity. He then entered a dual PhD in Machine Learning and Public Policy at Carnegie Mellon University, focused on helping policy makers and create more effective, intelligent, and just decisions. In 2017 he took these analytical approaches to help develop a novel way of providing stylish, affordable, and convenient adult incontinence products, allowing people to live proud and in style without losing their wallets.
Follow William Herlands:
About Willow: Willow is stylish, comfortable, affordable disposable underwear — delivered discreetly to your door at a fraction of the price.
Christopher McCann
CEO & Co-Founder of Current Health
I left school at the age of 16 and graduated with a Masters in Computer Science at age 21. At 20, I set up my first company, Dizeo – this was in social networking for children. This failed in 2011 but the experience taught me some of the most valuable lessons of my life. Around the same time, I was spending time in hospitals due to an unwell relative. I decided to go to medical school as a result in 2012. In 2014, I founded snap40 as a direct result of my experiences working in hospital. I was part of the care of patients who had deteriorated avoidably because the warning signs were detected late. I wanted a world where myself and my family would be treated preventatively at the earliest possible point. snap40 prevent illness by automatically detecting those at high risk. We’re a software company who uses our own wearable device, worn on the upper arm of the patient, to continuously monitor them. We then do predictive analytics to identify the patient who needs medical attention most and bring healthcare to them, far earlier. Please get in touch! E-mail: christopher@snap40.com
Follow Christopher McCann:
About Current Health: We help healthcare reduce risk & cost by monitoring, managing and engaging patients at home.
Fred Moll, M.D
CEO of Hansen Medical
Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical, Inc. (Nasdaq: ISRG). Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.
Follow Fred Moll, M.D:
About Hansen Medical, Hansen Medical, Intuitive Surgical, Johnson & Johnson, Sonder Capital: Hansen Medical designs and manufactures medical robotics for the accurate positioning and control of catheter-based technologies.
Kevin Rocco
Chief Executive Officer of Biorez
Kevin Rocco is Director, Chief Executive Officer at Biorez. He joined the company in February 2014 as the lead engineer, and in November 2016 was promoted to CEO and joined the Board of Directors. As CEO, Kevin has led a $1.5 million fundraising effort, rebranded the company, grown the Biorez team, and filed a new patent for Biorez’s lead ACL technology in March 2017. Prior to joining Biorez, Kevin studied tissue engineering at Yale University, where he coauthored 17 publications in the field and was a part of the research team with the first US clinical study of a bioresorbable vascular graft in human. Kevin began his career as an engineer in new technology development at Covidien (acquired by Medtronic) where he investigated a novel bioresorbable hernia mesh device. He holds a B.S. and M.S. in Biomedical Engineering from The University of Connecticut and Yale University, respectively.
Follow Kevin Rocco:
About Biorez, Paw Haven: Biorez is a medicine company focused on the development of tendon and ligament healing.
Gibb Clarke
CEO and Co-Founder of Blockade Medical
Gibb Clarke is co-founder and CEO of Blockade Medical and has more than 10 years experience as a medical device executive with a specific focus on new technology development for the interventional neurovascular marketplace. Prior to co-founding Blockade, Gibb co-founded Pulsar Vascular, Inc. in 2006. A novel therapeutic approach for challenging and complex cerebral aneurysms. Gibb successfully raised multiple rounds of venture capital as well as helped craft and manage the clinical and regulatory strategy for both CE Mark and US approvals. Prior to Pulsar, Gibb played a critical early role in helping Swedish Medical Center in Seattle, WA, plan for and execute the development of The Seattle Neuroscience Institute, a neuroscience center for excellence. Gibb’s efforts resulted in Swedish Medical investing in excess of $35M into the development of its now flagship neuroscience center located in Seattle, WA. Gibb also spent 8 years in the US Marines Corps serving as a team leader in the elite Marine Recon unit. Military schoolings include Amphibious Recon Course, Army Ranger School, US Navy Dive School, and Army Jump School. Gibb is an avid endurance athlete, having competed in over 200 races.
Follow Gibb Clarke:
About Blockade Medical: Founded in 2011, Blockade Medical is a privately held company dedicated the development of catheter based therapeutic devices for the
Rushika Fernandopulle
Co-Founder & Chief Executive Officer of Iora Health
Rushika Fernandopulle is Co-founder and CEO at Iora Health
Follow Rushika Fernandopulle:
About Health Rosetta Group, Iora Health: Iora Health is a healthcare company that helps patients manage their health and navigate the healthcare system.
Jeffrey Brewer
President & CEO of Bigfoot Biomedical
Follow Jeffrey Brewer:
About Bigfoot Biomedical: Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Don Listwin
CEO of RapidAI
Don Listwin is the CEO of RapidAI. Don Listwin is also a distinguished networking industry veteran with more than 20 years of experience, including a decade at Cisco Systems, and served as president and CEO of Openwave Systems Inc., the world’s leading provider of open software and services for the communications industry. Listwin helped launch NetAid, an innovative nonprofit organization that partners with the United Nations to provide corporations, groups and individuals concrete ways to fight extreme poverty in developing countries. Listwin is the founder of the Canary Foundation and a member of the Board of Trustees at the Fred Hutchinson Cancer Research Center in Seattle Washington.
Follow Don Listwin:
About Canary Foundation, RapidAI: RapidAI empowers clinicians to make faster, more accurate diagnostic and treatment decisions for stroke and aneurysm patients.
Billoo Rataul
President & CEO of Paramit Corporation
Billoo Rataul is the President & CEO at Paramit Corporation.
Follow Billoo Rataul:
About Paramit Corporation: Paramit designs and manufactures medical devices and life science instruments.
Stuart Hinchen
Co-Founder & CEO of QuVa Pharma
Stuart Hinchen is Founder &CEO @ QuVa Pharma. Stuart Hinchen is currently Chief Executive Officer of JHP Pharmaceuticals, LLC (“JHP”), having acted as President and Chief Operating Officer of JHP from 2007 to 2011. He has been instrumental in the establishment of JHP as a leading injectable pharmaceutical business in the USA. Previously, Stuart was President of Mayne Pharma Americas (“Americas”), a unit of Mayne with $180 million in revenue that was focused on the manufacture, development and sale of generic injectable pharmaceuticals, primarily into the hospital market. Stuart led the Americas activity through a period of significant growth through acquisition, product line extension, and product in-licensing. Having first established Mayne Pharma USA as a stand-alone business, he helped build the division into the fourth largest US generic oncology provider. Prior to his experience with Mayne Americas, Stuart was a General Manager in Mayne’s Mergers and Acquisitions Group, heading transactional and operational teams involved in the purchase, sale and integration of businesses. After joining Mayne in 1995, Stuart worked on a variety of different projects, including the restructuring and sale of the company’s Benelux logistics business to Hays PLC.
Follow Stuart Hinchen:
About QuVa Pharma: QuVa Pharma is a pharmaceutical company engaged in the innovation and production of pharmaceutical products.
Kelsey Mellard
CEO & Co-Founder of Sitka
Kelsey Mellard is the CEO and Founder of Sitka, a first-of-its-kind medical vConsults platform and specialty provider network. She launched Sitka in 2018 to help improve access to and delivery of specialty care across the nation. Prior to founding Sitka, Kelsey led Health System Integration at Honor, a comprehensive technology-backed home care company. Before joining the Honor, Kelsey led the development of the Post-Acute Care Center for Research (PACCR), which she served as its Executive Director. Kelsey also served in VP roles at naviHealth, UnitedHealth Group, the Center for Medicare and Medicaid Innovation (CMMI), and held positions at Advisory Board Company, Children’s Mercy Hospitals and Clinics, and Kaiser Family Foundation. Kelsey holds a Bachelor’s of Science Degree in Community Health from Winona State University and a Master’s degree in Public Administration from the University of Kansas. She also currently serves as an adjunct faculty member at Winona State University in the College of Nursing and Health Services.
Follow Kelsey Mellard:
About Sitka, Winona State University: Sitka is a customizable video software platform that connects primary care providers to the virtual specialty provider network.
Mark Mastalir
Co-CEO & Chief Marketing Officer of Halo Neuroscience
Follow Mark Mastalir:
About Halo Neuroscience: Halo Neuroscience is a neurotech company focused on using electrical neurostimulation to unlock human performance and treat human disease
Kurt Graves
President & CEO of Intarcia Therapeutics
Follow Kurt Graves:
About Intarcia Therapeutics: Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Maryam Ziaei
Co-Founder & Chief Executive Officer of iSono Health
Maryam Ziaei is the Co-Founder & CEO at iSono Health.
Follow Maryam Ziaei:
About iSono Health: iSono Health develops an AI platform for accessible and personalized breast health monitoring
Marshal Linder
Chairman, CEO of Breethe
Marshal Linder is the Chairman and CEO of Breethe, Inc.
Follow Marshal Linder:
About Breethe: Breethe is a medical device company that develops a compact artificial lung for patients with acute and chronic lung problems.
Elad Walach
CEO and Co-Founder of Aidoc
Elad Walach is a co-founder and CEO of Aidoc. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad has led the company through 2 rounds of investment (total of $13Mil), driven the commercial availability of 2 product lines (detecting brain hemorrhages and C-Spine fractures), and created an install base of 16 global health systems while growing the company to over 50 employees. Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and managed several teams focused on machine learning and computer vision projects. Elad holds a B.Sc. in Mathematics and Physics from The Hebrew University of Jerusalem, and has published multiple academic papers on deep learning.
Follow Elad Walach:
About Aidoc: Aidoc specializes in developing artificial intelligence tools for radiologists and multidisciplinary response teams.
Travis Rush
Co-founder & CEO of Reperio Health
Travis Rush has been developing web applications for companies all over the world since 1997. He is the owner of multiple online web solution services designed for specific markets. Travis is currently in the process of launching his first investor supported, subscription based, online service. In his spare time, he is also a songwriter and music producer with two albums released with country radio airplay and television video airplay, such as CMT and GAC. Travis is married and living in Portland, Oregon with two children and a third one on the way.
Follow Travis Rush:
About Reperio Health, Sightbox: Reperio is the only at-home health assessment that provides comprehensive results immediately.
Ren Menon
Co-Founder and CEO of OrthoFX
Ren Menon is currently serving as the managing director of Silicon Valley Capital where he is leading the firm’s diversification into the health and wellness sectors. Prior to Silicon Valley Capital, Mr. Menon held several leadership roles at Invisalign including head of global product development & innovation, head of North America commercial operations, Director – R & D and more. He played a critical role is helping grow Invisalign’s annual revenues to $900MM+ while attaining a market cap of $7B+. Mr. Menon was also the co-founder/CEO of Goldenslate – a big data analytics powered search engine to empower consumers to make informed, trust based choices when selecting critical care service providers. He exited his stake in Goldenslate through a planned sale. Over his 20 year career, he has held leadership roles in general management, product development, sales & marketing. Mr. Menon is currently a strategic advisor to Kairos society. He also sits on the board of SPCA and several privately held healthcare technology companies.
Follow Ren Menon:
About OrthoFX: Innovation Leader in Clear Aligner Orthodontics
J. Kurt Jacobus
Chairman and CEO of Restor3d
Kurt Jacobus is a Managing Director of the GRA Venture Fund.
Follow J. Kurt Jacobus:
About Restor3d: Restor3d offers surgeons with biomaterials, 3D printing technologies, and artificial intelligence to repair and rebuild the human body.
Aaron Hsu
CEO and Co-Founder of ClearMask
Clinical researcher turned Social Entrepreneur that is Making Healthcare More Human. Love helping other entrepreneurs help make the world a better place. Let’s connect and see how we can work together!
Follow Aaron Hsu:
About ClearMask, Johns Hopkins University School of Medicine: ClearMask™ is a company manufatures the first full-face, transparent surgical mask.
Ritankar Das
Founder & Chief Executive Officer of Dascena
Ritankar Das is the founder and CEO of Dascena
Follow Ritankar Das:
About Dascena: Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
Raymond W. Cohen
CEO of Axonics Modulation Technologies
Mr. Raymond Cohen is presently Chief Executive Officer of Vessix Medical, Inc.. He has over 28 years of experience in the medical technology field focused on new product development, creation of intellectual property, venture financing, sales and marketing, strategic planning and mergers and acquisitions. For the decade prior to 2006, Cohen served as Chairman and CEO of Nasdaq-listed Cardiac Science, Inc., which in 2004 was ranked as the 4th fastest growing technology company in North America on Deloitte & Touche’s Fast 500 listing and was recognized by Inc. Magazine on “The Innovation 50 – a listing of the most inventive small companies in entrepreneurial America”. Cohen also serves as member of the board of directors of Cardiogenesis Corp, BioLife Solutions, Inc. and Syncroness, Inc. Mr. Cohen holds a B.S. in Business Management from the State University of New York at Binghamton and is an Accredited Public Company Director.
Follow Raymond W. Cohen:
About Axonics Modulation Technologies, BioLife Solutions: Axonics Modulation Technologies is a pre-revenue company developing novel implantable neuromodulation.
Bill Gruber
President & CEO of Solace Therapeutics
Prior to this role as President and CEO of Solace Therapeutics, he co-founded Interlace Medical in August 2006 and served as their President and CEO until Interlace was acquired by Hologic in January 2011. Bill has extensive experience in organizational development and in product development for rapid growth businesses. Prior to Interlace, Bill spent five years at Cortek Inc., a spinal products company. As Cortek’s V.P. of Sales and Marketing, he built sales from $612K to over $10M. During his last two years, he was the V.P. of New Business Development and Marketing. In this role, he was instrumental in creating Soteira, a Cortek subsidiary, focused on devices for treating vertebral compression fractures. Prior to Cortek, Bill spent 10 years at Boston Scientific Corporation. Before leaving Boston Scientific Corporation, he held the position of Director of the $172M Global Atherosclerotic Therapy business. Prior to entering the medical device sector, Bill spent five years in sales and marketing roles at Procter and Gamble.
Follow Bill Gruber:
About Solace Therapeutics: Solace Therapeutics develops and commercializes non-surgical office-based treatments for common bladder disorders.
Paul Buckman
President & CEO of SentreHEART
Paul Buckman has more than 30 years of experience as a business leader and executive in the medical device and medical technology industry, holding positions at SentreHeart, Pathway Medical Technologies, St. Jude Medical, ev3, Scimed/Boston Scientific and others. He has also served on the Board of Directors for businesses including SentreHEART, Sunshine Heart, Devax, Velocimed, EndiCor, Microvena, Micro Therapeutics, ev3 and Conventus. Mr. Buckman earned his Master’s degree in Business Administration and Finance and B.A. degree in Business Administration from Western Michigan University (Kalamazoo, Michigan).
Follow Paul Buckman:
About SentreHEART: SentreHEART is a medical device company developing tissue closure solutions, offering physicians control over remotely delivered sutures.
Jianlu Ma
CEO of NeuroVasc Technologies
Jim Ma founded Neurovasc Technologies Inc. in August of 2015, with a unique background in serial medical device development, clinical evaluation, and commercialization experience. Prior to starting Neurovasc, Mr. Ma founded Marvel Medical Technologies in 2011 and served as its General Manager. Prior to that, he had worked with several major medical device companies and managed R&D activities for 22 years. Mr. Ma received a Bachelor of Arts degree from Xi’an Technological University and his Master of Science degree from Florida International University. Mr. Ma has 23 issued US patents and over 46 US patent applications related to vascular devices.
Follow Jianlu Ma:
About ev3, NeuroVasc Technologies: NeuroVasc Technologies is a medical device company that develops a catheter-based technology to treat neurovascular diseases.
David Benshoof Klein
Founder & CEO of Click Therapeutics
David Benshoof Klein is a healthcare investor and entrepreneur with over 13 years life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, Mr. Klein co-founded Click Therapeutics, Inc. which focuses on engineering, validating and commercializing Digital Therapeutics™ applications to benefit people with brain disorders and neuropsychiatric dysfunction. He formerly served as Managing Director at a life science asset management firm & senior consultant to Pfizer.
Follow David Benshoof Klein:
About Click Therapeutics: Click Therapeutics delivers safe and effective digital treatments to patients in need.
Vincent Lopez
Founder & CEO of LCA Vantage
Vincent Lopez is the founder & CEO of LCA Vantage Healthcare d/b/a Parker Health an innovative biotechnology company advancing healthcare into the next century. At Parker Health he is the chief visionary leading strategy & government affairs working closely with Congress and the National Coordinator for Health information Technology office to inform their results to economize spending, minimize legacy technology costs and inefficiencies, enhance patient care, and deploy the latest healthcare technology.
He is the founder of the Lopez Foundation, Inc., a 501 (c)(3) nonprofit. In 2015, he was nominated to the Pennsylvania State System of Higher Education (PASSHE) Board of Governors by Governor Tom Wolf (D-PA), He’s the former student body president of Indiana University of Pennsylvania and chairman of the PASSHE Board of Student Government Presidents. He completed a Fellowship with an emphasis on STEM education in minority communities (7th Ward, Washington, DC), with then-President Obama’s Organizing for Action. He has worked for the US. Department of Homeland Security.
A native of Sacramento, California, Mr. Lopez was raised in Arlington, Virginia. He studied at the Indiana University of Pennsylvania, where he majored in English. He’s an avid golfer, and a fan of Formula 1 racing, horse racing, and fishing.
Follow Vincent Lopez:
About LCA CORP, LCA Vantage, The Lopez Foundation,Inc.: Electronic Health Records, Remote Physiological Monitoring, Biometrics, FHIR Complaint, Health Subscriptions
Dow Wilson
President and Chief Executive Officer of Varian
Dow R. Wilson is president and chief executive officer of Varian Medical Systems, a NYSE-listed medical device manufacturer with more than $3.3 billion in global sales. Varian designs and manufactures advanced equipment and software products for treating cancer with radiation as well as imaging components used in imaging and security applications. Mr. Wilson is also a member of the company’s Board of Directors.
Follow Dow Wilson:
About Varian: Varian Medical Systems is a manufacturer of medical devices and software for treating cancer and other medical conditions.
Ron Zwanziger
Co-Founder, Chief Executive Officer, Chairman, and Director of LumiraDx
Ron Zwanziger, a strategic visionary and entrepreneur, is the CEO of LumiraDx, which he co-founded in 2014. He previously founded and led numerous successful diagnostic firms, including Alere, Inverness Medical Technology (which was acquired by Johnson & Johnson in 2001), and MediSense, the first company to introduce an electrochemical glucose sector. He currently serves on the Board of Directors of several private companies.
Follow Ron Zwanziger:
About LumiraDx: LumiraDx is a healthcare company that manufactures a diagnostic platform to support a menu of tests with lab comparable performance.
Elaine Horn-Ranney
Co-Founder & CEO of Tympanogen, Inc.
Elaine received both her BS and PhD in Biomedical Engineering from Tulane University. She possesses a robust knowledge of biomaterials and is experienced in synthesizing materials for tissue engineering and regenerative medicine applications, with a specialized focus on translating laboratory research into clinical products. Elaine has led the team and research projects since 2011.
Follow Elaine Horn-Ranney:
About Tympanogen, Inc.: Tympanogen is a medical technology company that develops ear, nose, and throat (ENT) devices and wound-healing therapies.
Olaf Schermeier
Member of the Management Board – CEO Global R&D of Fresenius Medical Care
Olaf Schermeier was appointed Chief Executive Officer for Global Research and Development on March 1, 2013. Previously, he served as president of global R&D for Draeger Medical, Lübeck, Germany. Schermeier has many years of experience in various areas of the health care industry, among others at Charité-clinic and Biotronik, Germany. He holds a doctorate degree (PhD) in Computer Science from the Technical University of Berlin, Germany and graduated from the University of Hannover, Germany in Electrical Engineering.
Follow Olaf Schermeier:
About Fresenius Medical Care: Fresenius Medical Care is a healthcare company that provides dialysis treatment for those with chronic kidney diseases.
Anthony Dohrmann
Chief Executive Officer & Founder of Electronic Caregiver Inc.
Anthony Dohrmanns’ Electronic Caregiver Inc. is a leading health technology innovator, designing, marketing, and monitoring state-of-the-art home monitoring and health management systems including Addison Care, which leverages ambient augmented reality and leading-edge A.I. technologies. Electronic Caregiver Inc. is marked by integrity and the willingness to exceed expectations. ECG engineers smart technologies that radically change the quality of patient home care, family life, and beyond. It’s products drastically improve security outcomes and compel faster, affordable preventions and emergency interventions. The Electronic Caregiver message and the message of Anthony Dohrmann is one and the same; it is the message of active aging, aging well, and living life to the fullest while being completely protected.
Follow Anthony Dohrmann:
About Electronic Caregiver Inc., Safari Christian Business Alliance: Health and emergency systems for connected care, remote patient monitoring and health management leveraging leading-edge technologies.
Tom Afzal
Chief Executive Officer of Novum Medical
Chief Executive Officer and Board Member at Novum Medical, Inc.
Follow Tom Afzal:
About Neuroventis, Novum Medical: Novum Medical develops biocompatible materials with broad applications for musculoskeletal clinical practices.
Jeff Franco
Founder, President and CEO of Tendyne Holdings
Jeff Franco is President and CEO,Board of Director at Tendyne Holdings.
Follow Jeff Franco:
About Tendyne Holdings: Tendyne is a medical device company developing a transcatheter aortic valve implantation system.
David Hochman
Chief Executive Officer and Founder of Orchestra BioMed
David Hochman is a Managing Partner of Orchestra. He has over 14 years of venture capital and investment banking experience. He is also President of Accelerated Technologies, Inc (ATI), a medical device accelerator managed by Orchestra. Prior to joining Orchestra, Mr. Hochman was Chief Executive Officer of Spencer Trask Edison Partners, LLC, a principal investment partnership focused on early stage healthcare companies. He was also Managing Director of Spencer Trask Ventures, Inc. during which time he was responsible for directing the firm’s venture banking group and led financing transactions for over 20 early-stage companies, securing over $420 million in equity capital. Mr. Hochman currently serves as a director of Caliber Therapeutics, Vital Access, BackBeat Medical, and Prescient Medical, Inc., an interventional cardiovascular device company Mr. Hochman co-founded in 2004. Mr. Hochman was an advisor and observer to the board of Health Dialog Services Corporation, a world leader in collaborative care management that was acquired in 2008 by the British United Provident Association for $750 million. He was also a co-founder and director of PROLOR Biotech, Inc., a biopharmaceutical company developing longer-lasting versions of approved therapeutic proteins, as well as a board advisor to Idera Pharmaceuticals, Inc., a world leader in Toll-Like Receptor-based therapeutics. Mr. Hochman currently serves as a director of the following nonprofit organizations: the Citizens Committee for New York City, the AIDS Action Foundation; and the Mollie Parnis Livingston Foundation. He graduated with honors from the University of Michigan.
Follow David Hochman:
About Orchestra BioMed, Orchestra Medical Ventures: Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
